Literature DB >> 24835760

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Francisco A Folgar1, Glenn J Jaffe1, Gui-Shuang Ying2, Maureen G Maguire2, Cynthia A Toth3.   

Abstract

OBJECTIVE: To determine agreement between spectral-domain (SD) and time-domain (TD) optical coherence tomography (OCT) image assessments by certified readers in eyes treated for neovascular age-related macular degeneration (AMD).
DESIGN: Cross-sectional study within the Comparison of AMD Treatments Trials (CATT). PARTICIPANTS: During year 2 of CATT, 1213 pairs of SD OCT and TD OCT scans were compared from a subset of 384 eyes.
METHODS: Masked readers independently graded OCT scans for presence of intraretinal fluid (IRF), subretinal fluid (SRF), and sub-retinal pigment epithelium (RPE) fluid and performed manual measurements of retinal, SRF, and subretinal tissue complex thicknesses at the foveal center. MAIN OUTCOME MEASURES: Presence of fluid was evaluated with percent agreement, κ coefficients with 95% confidence intervals (CIs), and McNemar tests. Thickness measurements were evaluated with mean difference (Δ) ±95% limits of agreement and intraclass correlation coefficients (ICCs) with 95% CIs.
RESULTS: Between SD OCT and TD OCT, agreement on presence of any fluid was 82% (κ = 0.46; 95% CI, 0.40-0.52), with 5% more SD OCT scans demonstrating fluid (P<0.001). Agreement on presence of SRF was 87% and sub-RPE fluid was 80%, with more SD OCT scans demonstrating fluid (both P < 0.001). Agreement on IRF was 73% (κ = 0.47; 95% CI, 0.42-0.52), with 6% more TD OCT scans demonstrating fluid (P < 0.001). Between SD OCT and TD OCT, mean thickness of the retina was Δ = 5±67 μm, SRF was Δ = 1.5±35 μm, and subretinal tissue complex was Δ = 5±86 μm. Thickness measurements were reproducible for retina (ICC = 0.84; 95% CI, 0.83-0.86), SRF (ICC = 0.88; 95% CI, 0.86-0.89), and subretinal tissue complex (ICC = 0.91; 95% CI, 0.89-0.92), with ≤25-μm difference in these measurements in 71%, 94%, and 61% of paired scans, respectively.
CONCLUSIONS: Agreement on fluid presence and manual thickness measurements between paired scans from each OCT modality was moderate, providing a reasonable basis to compare CATT results with future SD OCT-based trials. Fluid was detected 5% more frequently with SD OCT, which may increase frequency of fluid-based treatment. Lower-resolution and artifactual interpretation of dark areas as cystoid edema may explain the greater frequency of IRF detected with TD OCT.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24835760      PMCID: PMC4515372          DOI: 10.1016/j.ophtha.2014.04.020

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  28 in total

1.  Interobserver variability in optical coherence tomography for macular edema.

Authors:  David J Browning
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

2.  Quantitative thickness measurement of retinal layers imaged by optical coherence tomography.

Authors:  Mahnaz Shahidi; Zhangwei Wang; Ruth Zelkha
Journal:  Am J Ophthalmol       Date:  2005-06       Impact factor: 5.258

3.  Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging.

Authors:  Teresa C Chen; Barry Cense; Mark C Pierce; Nader Nassif; B Hyle Park; Seok H Yun; Brian R White; Brett E Bouma; Guillermo J Tearney; Johannes F de Boer
Journal:  Arch Ophthalmol       Date:  2005-12

4.  Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes.

Authors:  Ian C Han; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2009-02-06       Impact factor: 5.258

5.  Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography.

Authors:  Christopher Kai-shun Leung; Carol Yim-lui Cheung; Robert N Weinreb; Gary Lee; Dusheng Lin; Chi Pui Pang; Dennis S C Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

6.  Is quantitative spectral-domain superior to time-domain optical coherence tomography (OCT) in eyes with age-related macular degeneration?

Authors:  Urban Eriksson; Albert Alm; Eva Larsson
Journal:  Acta Ophthalmol       Date:  2011-03-04       Impact factor: 3.761

7.  A general methodology for the analysis of experiments with repeated measurement of categorical data.

Authors:  G G Koch; J R Landis; J L Freeman; D H Freeman; R C Lehnen
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

8.  Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.

Authors:  Francis Char DeCroos; Cynthia A Toth; Sandra S Stinnett; Cynthia S Heydary; Russell Burns; Glenn J Jaffe
Journal:  Ophthalmology       Date:  2012-08-28       Impact factor: 12.079

9.  Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis.

Authors:  Francisco A Folgar; Cynthia A Toth; Francis Char DeCroos; Aniz Girach; Steve Pakola; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-25       Impact factor: 4.799

10.  Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.

Authors:  Gui-shuang Ying; Jiayan Huang; Maureen G Maguire; Glenn J Jaffe; Juan E Grunwald; Cynthia Toth; Ebenezer Daniel; Michael Klein; Dante Pieramici; John Wells; Daniel F Martin
Journal:  Ophthalmology       Date:  2012-10-06       Impact factor: 12.079

View more
  14 in total

1.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Thomas A Ciulla; Thomas A Cuilla; Gui-Shuang Ying; Maureen G Maguire; Daniel F Martin; Glenn J Jaffe; Juan E Grunwald; Ebenezer Daniel; Cynthia A Toth
Journal:  Ophthalmology       Date:  2015-03-29       Impact factor: 12.079

3.  IDENTIFICATION OF FLUID ON OPTICAL COHERENCE TOMOGRAPHY BY TREATING OPHTHALMOLOGISTS VERSUS A READING CENTER IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

Authors:  Cynthia A Toth; Francis Char Decroos; Gui-Shuang Ying; Sandra S Stinnett; Cynthia S Heydary; Russell Burns; Maureen Maguire; Daniel Martin; Glenn J Jaffe
Journal:  Retina       Date:  2015-07       Impact factor: 4.256

4.  Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

Authors:  Meidong Zhu; Jamie K Chew; Geoffrey K Broadhead; Kehui Luo; Nichole Joachim; Thomas Hong; Adil Syed; Andrew A Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-10       Impact factor: 3.117

5.  Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Ebenezer Daniel; Gui-Shuang Ying; Benjamin J Kim; Cynthia A Toth; Frederick Ferris; Daniel F Martin; Juan E Grunwald; Glenn J Jaffe; Joshua L Dunaief; Wei Pan; Maureen G Maguire
Journal:  Ophthalmology       Date:  2018-11-23       Impact factor: 12.079

6.  Whole-body positional manipulators for ocular imaging of anaesthetised mice and rats: a do-it-yourself guide.

Authors:  Michael Dietrich; Andrés Cruz-Herranz; Hao Yiu; Orhan Aktas; Alexander U Brandt; Hans-Peter Hartung; Ari Green; Philipp Albrecht
Journal:  BMJ Open Ophthalmol       Date:  2016-11-06

7.  VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION.

Authors:  Lala Ceklic; Marion R Munk; Ute Wolf-Schnurrbusch; Margarita Gekkieva; Sebastian Wolf
Journal:  Retina       Date:  2017-04       Impact factor: 4.256

Review 8.  A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion.

Authors:  Juan Lyn Ang; Sarah Ah-Moye; Leah N Kim; Vuong Nguyen; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-04-20       Impact factor: 3.775

9.  Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Avni P Finn; Maxwell Pistilli; Vincent Tai; Ebenezer Daniel; Gui-Shuang Ying; Maureen G Maguire; Juan E Grunwald; Daniel F Martin; Glenn J Jaffe; Cynthia A Toth
Journal:  Am J Ophthalmol       Date:  2020-11-19       Impact factor: 5.258

10.  Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Jason Q Core; Maxwell Pistilli; Ebenezer Daniel; Juan E Grunwald; Cynthia A Toth; Glenn J Jaffe; Peiying Hua; Daniel F Martin; Gui-Shuang Ying; Maureen G Maguire
Journal:  Ophthalmol Retina       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.